Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | TOI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.23 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.33 - 2.655 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.23 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.41 | 1.41 | 1.14 | 1.21 | 88,434 | -0.18 | -12.77% |
1 Month | 1.38 | 1.89 | 1.14 | 1.49 | 128,485 | -0.15 | -10.87% |
3 Months | 2.09 | 2.225 | 1.14 | 1.68 | 114,402 | -0.86 | -41.15% |
6 Months | 1.60 | 2.655 | 1.07 | 1.83 | 216,524 | -0.37 | -23.13% |
1 Year | 0.5371 | 2.655 | 0.33 | 1.02 | 378,250 | 0.6929 | 129.01% |
3 Years | 9.86 | 12.66 | 0.33 | 2.14 | 240,527 | -8.63 | -87.53% |
5 Years | 9.86 | 12.66 | 0.33 | 2.14 | 240,527 | -8.63 | -87.53% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |